SCHEMBL8974658

SCHEMBL8974658

NS(=O)(=O)c1ccc(C2=CC(C(=O)O)C=C2c2ccc(F)cc2)nc1

nearest known ligand 0.41

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CA2 P00918 10/20 0.41
CA1 P00915 9/20 0.41
CA9 Q16790 7/20 0.41
CA4 P22748 6/20 0.41
CA5A P35218 3/20 0.41
CA5B Q9Y2D0 3/20 0.41
MAOA P21397 2/20 0.39
MAOB P27338 1/20 0.39
PTGS2 P35354 8/20 0.39
PTGS1 P23219 4/20 0.39
CA12 O43570 3/20 0.37
CA7 P43166 3/20 0.37
NPC1 O15118 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8974071 0.93 CA2 (0.41) CA2CA1CA9CA4CA5A
SCHEMBL8974083 0.88 PTGDR2 (0.43) PTGS2PTGS1
SCHEMBL8974768 0.87 KIF11 (0.47) CA2CA1CA9CA4MAOB
SCHEMBL8974416 0.87 CA2 (0.41) CA2CA1CA9CA4CA5A
SCHEMBL8974810 0.86 PTGS1 (0.51) CA2CA1CA9CA4MAOA
SCHEMBL8974602 0.85 CA2 (0.44) CA2CA1CA9CA4CA5A
SCHEMBL8974356 0.84 CA2 (0.43) CA2CA1CA9CA4CA5A
SCHEMBL8974747 0.83 PTGS2 (0.42) CA2CA1CA9CA4CA5A
SCHEMBL8973806 0.83 PTGS2 (0.43) PTGS2PTGS1
SCHEMBL8973730 0.83 KIF11 (0.47) CA2CA1CA9CA4PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5576339-A Pyridyl substituted cyclopentadienes for the treatment of inflamation HUANG HORNG-CHIH (US) 1996-11-19 US disclosed
WO-1995030656-A1 SUBSTITUTED CYCLOPENTADIENYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1995-11-16 WO disclosed
US-5418254-A Side effect reduction G. D. SEARLE & CO. (US) 1995-05-23 US disclosed